Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof

The present invention discloses a recombinant canine adenovirus-2 transfer vector, a method for constructing the recombinant canine adenovirus-2 transfer vector and an applications thereof. The recombinant canine adenovirus-2 transfer vector loses the 1412bp fragment of the E3 region, a large fragme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LI CHANGWEN, JIANG QIAN, SI CHANGDE, QU LIANDONG, ZHANG HONGYING, LIU LIKUI, ZHOU JIE, MENG QINGWEN, LIU JIASEN, HAN LINGXIA, CHEN HONGYAN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LI CHANGWEN
JIANG QIAN
SI CHANGDE
QU LIANDONG
ZHANG HONGYING
LIU LIKUI
ZHOU JIE
MENG QINGWEN
LIU JIASEN
HAN LINGXIA
CHEN HONGYAN
description The present invention discloses a recombinant canine adenovirus-2 transfer vector, a method for constructing the recombinant canine adenovirus-2 transfer vector and an applications thereof. The recombinant canine adenovirus-2 transfer vector loses the 1412bp fragment of the E3 region, a large fragment of exogenous gene can be inserted, and moreover, a hCMV IE promoter, a multiple cloning site, an enhanced green fluorescent protein gene and a SV40 early transcribed Poly A signal sequence can be inserted in the position of the lost fragment of the E3 region. The method successfully constructs the lost recombinant CAV-2 transfer vector of the E3 region, obtains a purified canine adenovirus-2 strain containing EGFP reporter gene and optimizes the cloning and purification method thereof, an evaluation indicates that the biological property of the recombinant virus is stable, and therefore the present invention provides a technical platform for the further development of CAV-2 live vector vaccine and related fundam
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN101358202A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN101358202A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN101358202A3</originalsourceid><addsrcrecordid>eNqNir0KwkAQBtNYiPoOa6-QHwRbCYqVhdiH9fKFHCS7x90m4Nsr4gNYDAPDLDO-w-n49MJi5Fi8gLiF6OzjlMheAVSSRZbUIdIMZxp35FSSxcmZV6ER1mtLLB9CGLzjb7YeEdqts0XHQ8Lm51W2vZwf9XWPoA1SYAeBNfWtyIvqcCzz8lT987wBUTE-LA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof</title><source>esp@cenet</source><creator>LI CHANGWEN ; JIANG QIAN ; SI CHANGDE ; QU LIANDONG ; ZHANG HONGYING ; LIU LIKUI ; ZHOU JIE ; MENG QINGWEN ; LIU JIASEN ; HAN LINGXIA ; CHEN HONGYAN</creator><creatorcontrib>LI CHANGWEN ; JIANG QIAN ; SI CHANGDE ; QU LIANDONG ; ZHANG HONGYING ; LIU LIKUI ; ZHOU JIE ; MENG QINGWEN ; LIU JIASEN ; HAN LINGXIA ; CHEN HONGYAN</creatorcontrib><description>The present invention discloses a recombinant canine adenovirus-2 transfer vector, a method for constructing the recombinant canine adenovirus-2 transfer vector and an applications thereof. The recombinant canine adenovirus-2 transfer vector loses the 1412bp fragment of the E3 region, a large fragment of exogenous gene can be inserted, and moreover, a hCMV IE promoter, a multiple cloning site, an enhanced green fluorescent protein gene and a SV40 early transcribed Poly A signal sequence can be inserted in the position of the lost fragment of the E3 region. The method successfully constructs the lost recombinant CAV-2 transfer vector of the E3 region, obtains a purified canine adenovirus-2 strain containing EGFP reporter gene and optimizes the cloning and purification method thereof, an evaluation indicates that the biological property of the recombinant virus is stable, and therefore the present invention provides a technical platform for the further development of CAV-2 live vector vaccine and related fundam</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090204&amp;DB=EPODOC&amp;CC=CN&amp;NR=101358202A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090204&amp;DB=EPODOC&amp;CC=CN&amp;NR=101358202A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI CHANGWEN</creatorcontrib><creatorcontrib>JIANG QIAN</creatorcontrib><creatorcontrib>SI CHANGDE</creatorcontrib><creatorcontrib>QU LIANDONG</creatorcontrib><creatorcontrib>ZHANG HONGYING</creatorcontrib><creatorcontrib>LIU LIKUI</creatorcontrib><creatorcontrib>ZHOU JIE</creatorcontrib><creatorcontrib>MENG QINGWEN</creatorcontrib><creatorcontrib>LIU JIASEN</creatorcontrib><creatorcontrib>HAN LINGXIA</creatorcontrib><creatorcontrib>CHEN HONGYAN</creatorcontrib><title>Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof</title><description>The present invention discloses a recombinant canine adenovirus-2 transfer vector, a method for constructing the recombinant canine adenovirus-2 transfer vector and an applications thereof. The recombinant canine adenovirus-2 transfer vector loses the 1412bp fragment of the E3 region, a large fragment of exogenous gene can be inserted, and moreover, a hCMV IE promoter, a multiple cloning site, an enhanced green fluorescent protein gene and a SV40 early transcribed Poly A signal sequence can be inserted in the position of the lost fragment of the E3 region. The method successfully constructs the lost recombinant CAV-2 transfer vector of the E3 region, obtains a purified canine adenovirus-2 strain containing EGFP reporter gene and optimizes the cloning and purification method thereof, an evaluation indicates that the biological property of the recombinant virus is stable, and therefore the present invention provides a technical platform for the further development of CAV-2 live vector vaccine and related fundam</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNir0KwkAQBtNYiPoOa6-QHwRbCYqVhdiH9fKFHCS7x90m4Nsr4gNYDAPDLDO-w-n49MJi5Fi8gLiF6OzjlMheAVSSRZbUIdIMZxp35FSSxcmZV6ER1mtLLB9CGLzjb7YeEdqts0XHQ8Lm51W2vZwf9XWPoA1SYAeBNfWtyIvqcCzz8lT987wBUTE-LA</recordid><startdate>20090204</startdate><enddate>20090204</enddate><creator>LI CHANGWEN</creator><creator>JIANG QIAN</creator><creator>SI CHANGDE</creator><creator>QU LIANDONG</creator><creator>ZHANG HONGYING</creator><creator>LIU LIKUI</creator><creator>ZHOU JIE</creator><creator>MENG QINGWEN</creator><creator>LIU JIASEN</creator><creator>HAN LINGXIA</creator><creator>CHEN HONGYAN</creator><scope>EVB</scope></search><sort><creationdate>20090204</creationdate><title>Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof</title><author>LI CHANGWEN ; JIANG QIAN ; SI CHANGDE ; QU LIANDONG ; ZHANG HONGYING ; LIU LIKUI ; ZHOU JIE ; MENG QINGWEN ; LIU JIASEN ; HAN LINGXIA ; CHEN HONGYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN101358202A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LI CHANGWEN</creatorcontrib><creatorcontrib>JIANG QIAN</creatorcontrib><creatorcontrib>SI CHANGDE</creatorcontrib><creatorcontrib>QU LIANDONG</creatorcontrib><creatorcontrib>ZHANG HONGYING</creatorcontrib><creatorcontrib>LIU LIKUI</creatorcontrib><creatorcontrib>ZHOU JIE</creatorcontrib><creatorcontrib>MENG QINGWEN</creatorcontrib><creatorcontrib>LIU JIASEN</creatorcontrib><creatorcontrib>HAN LINGXIA</creatorcontrib><creatorcontrib>CHEN HONGYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI CHANGWEN</au><au>JIANG QIAN</au><au>SI CHANGDE</au><au>QU LIANDONG</au><au>ZHANG HONGYING</au><au>LIU LIKUI</au><au>ZHOU JIE</au><au>MENG QINGWEN</au><au>LIU JIASEN</au><au>HAN LINGXIA</au><au>CHEN HONGYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof</title><date>2009-02-04</date><risdate>2009</risdate><abstract>The present invention discloses a recombinant canine adenovirus-2 transfer vector, a method for constructing the recombinant canine adenovirus-2 transfer vector and an applications thereof. The recombinant canine adenovirus-2 transfer vector loses the 1412bp fragment of the E3 region, a large fragment of exogenous gene can be inserted, and moreover, a hCMV IE promoter, a multiple cloning site, an enhanced green fluorescent protein gene and a SV40 early transcribed Poly A signal sequence can be inserted in the position of the lost fragment of the E3 region. The method successfully constructs the lost recombinant CAV-2 transfer vector of the E3 region, obtains a purified canine adenovirus-2 strain containing EGFP reporter gene and optimizes the cloning and purification method thereof, an evaluation indicates that the biological property of the recombinant virus is stable, and therefore the present invention provides a technical platform for the further development of CAV-2 live vector vaccine and related fundam</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN101358202A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A34%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI%20CHANGWEN&rft.date=2009-02-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN101358202A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true